High-density lipoprotein functionality, cardiovascular health, and patterns of alcohol consumption: new insights and future perspectives

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Purpose of reviewCardiovascular diseases (CVD) pose a significant public health challenge, contributing to 422 million disability-adjusted life years in 2021. The role of high-density lipoproteins (HDL) and alcohol consumption, one of their major modifiable determinants, remains controversial. The objective of this review is to provide a comprehensive narrative overview of HDL functionality and its predictive value for CVD in relation to patterns of alcohol consumption.Recent findingsHDL phenotypes beyond HDL-cholesterol (HDL-c) such as distribution of HDL subspecies, HDL particle abundance, and reverse cholesterol transport capacity are promising indicators of atherosclerotic CVD risk. Low-to-moderate alcohol consumption seems to improve HDL functionality and reduce the incidence of CVD among primarily middle-aged men and postmenopausal women. Advancements in our understanding of HDL biogenesis, structure, and function hold promise for improving HDL-related measures and their predictive value for cardiovascular health.SummaryLow-to-moderate alcohol consumption appears to not only increase HDL-c concentration found in the HDL fraction of plasma but also enhance HDL functionality, providing insights into the underlying mechanisms linking alcohol exposure and cardiovascular health benefits. However, rigorous, well designed intervention trials of alcohol consumption on hard cardiovascular outcomes are needed to identify robust causal associations of HDL phenotypes and alcohol consumption with cardiovascular risk.

OriginalsprogEngelsk
TidsskriftCurrent Opinion in Lipidology
Vol/bind35
Udgave nummer1
Sider (fra-til)25-32
Antal sider8
ISSN0957-9672
DOI
StatusUdgivet - 2024

Bibliografisk note

Funding Information:
Funding: MTS and MGF are supported by Novo Nordisk Research grant NNF18CC0034900.

Funding Information:
K.J.M. was the principal investigator of project U10AA025286 from the US National Institutes of Health, which received partial support from industry contributions to the Foundation for NIH from 2016 to 2018.

Publisher Copyright:
© 2024 Lippincott Williams and Wilkins. All rights reserved.

ID: 378808665